Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134563) titled 'Intensive lipid-lowering and plaque regression in symptomatic intracranial atherosclerotic stenosis patients with high-risk lipid subfractions: A prospective single-center real-world study' on Oct. 16.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First People's Hospital of Foshan
Condition:
Symptomatic ICAS patients
Intervention:
Intensive Combination Group, IC:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2027-01-01
Target Sample Size: Intensive Combination Group, IC:100;Standard of Care Group, SoC:100;
Countries of Recruitment:
Chi...